These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9358486)

  • 41. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation.
    Lévy S; Ricard P; Lau CP; Lok NS; Camm AJ; Murgatroyd FD; Jordaens LJ; Kappenberger LJ; Brugada P; Ripley KL
    J Am Coll Cardiol; 1997 Mar; 29(4):750-5. PubMed ID: 9091520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment.
    Kühlkamp V; Mewis C; Suchalla R; Mermi J; Dörnberger V; Seipel L
    Int J Cardiol; 1999 Jun; 69(3):271-9. PubMed ID: 10402110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrillation.
    Sra J; Biehl M; Blanck Z; Dhala A; Jazayeri MR; Deshpande S; Akhtar M
    Pacing Clin Electrophysiol; 1998 May; 21(5):1105-10. PubMed ID: 9604243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results.
    Lévy S; Ricard P; Gueunoun M; Yapo F; Trigano J; Mansouri C; Paganelli F
    Circulation; 1997 Jul; 96(1):253-9. PubMed ID: 9236442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intra-atrial defibrillation of human atrial fibrillation.
    Santini M; Pandozi C; Gentilucci G; Villani M; Scianaro MC
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S170-6. PubMed ID: 9727694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High Internal Atrial Defibrillation Threshold Is Related to a High Risk of Recurrence After Catheter Ablation for Long-Standing Persistent Atrial Fibrillation But Not for Persistent Atrial Fibrillation.
    Imaoka T; Kanzaki Y; Morita Y; Watanabe N; Furui K; Yoshioka N; Shibata N; Yamauchi R; Miyazawa H; Shimojo K; Sakamoto G; Ohi T; Goto H; Mitsuhashi H; Morishima I
    Heart Lung Circ; 2022 Sep; 31(9):1277-1284. PubMed ID: 35667971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of recent onset atrial fibrillation with intravenous sotalol and/or flecainide.
    Peters FP; Braat SH; Heymeriks J; Wellens HJ
    Neth J Med; 1998 Sep; 53(3):93-6. PubMed ID: 9803139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations.
    Saksena S; Prakash A; Mangeon L; Varanasi S; Kolettis T; Mathew P; De Groot P; Mehra R; Krol RB
    Am J Cardiol; 1995 Nov; 76(12):913-21. PubMed ID: 7484831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.
    Bianconi L; Mennuni M; Lukic V; Castro A; Chieffi M; Santini M
    J Am Coll Cardiol; 1996 Sep; 28(3):700-6. PubMed ID: 8772759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-response relationship for successful internal atrial defibrillation.
    Tse HF; Lau CP; Ayers GM
    Pacing Clin Electrophysiol; 2003 May; 26(5):1249-53. PubMed ID: 12765454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New concepts in atrial defibrillation.
    Ayers GM
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():155-61. PubMed ID: 10590503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low energy internal atrial cardioversion in atrial fibrillation lasting more than a year.
    Boriani G; Biffi M; Pergolini F; Zannoli R; Branzi A; Magnani B
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):243-6. PubMed ID: 9990639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the defibrillation threshold in atrial fibrillation by transoesophageal cardioversion using a biphasic impulse.
    Prochaczek F; Winiarska H; Kończakowski P; Pyka R; Dziuk D; Gałecka J
    Kardiol Pol; 2006 Apr; 64(4):373-9; discussion 380-2. PubMed ID: 16699980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Marked reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans.
    Cooper RA; Plumb VJ; Epstein AE; Kay GN; Ideker RE
    Circulation; 1998 Jun; 97(25):2527-35. PubMed ID: 9657473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Marked reduction in atrial defibrillation thresholds with repeated internal cardioversion.
    Ammer R; Lehmann G; Plewan A; Puetter K; Alt E
    J Am Coll Cardiol; 1999 Nov; 34(5):1569-76. PubMed ID: 10551708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transvenous atrial cardioversion threshold in patients with implantable cardioverter defibrillator: influence of active pectoral can.
    Heisel A; Jung J; Nikoloudakis N; Fries R; Schäfers HJ; Schieffer H
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):253-7. PubMed ID: 9990641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation.
    Van Gelder IC; Tuinenburg AE; Schoonderwoerd BS; Tieleman RG; Crijns HJ
    Am J Cardiol; 1999 Nov; 84(9A):147R-151R. PubMed ID: 10568674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
    van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction of atrial defibrillation threshold with an interatrial septal electrode.
    Zheng X; Benser ME; Walcott GP; Girouard SD; Rollins DL; Smith WM; Ideker RE
    Circulation; 2000 Nov; 102(21):2659-64. PubMed ID: 11085971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillation.
    Tse HF; Lau CP
    J Am Coll Cardiol; 2002 Dec; 40(12):2150-5. PubMed ID: 12505228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.